Methylation of estrogen receptor 1 in colorectal adenomas is not age-dependent, but is correlated with K-ras mutation

Cancer Science

Volumn 100, Issue 6, 2009, Pages 1005-1011

  Horii, Joichiro ^a   Hiraoka, Sakiko ^a   Kato, Jun ^a   Saito, Shunsuke ^a   Harada, Keita ^a   Fujita, Hideyuki ^a   Kaji, Eisuke ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GUANINE; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; ESR1 PROTEIN, HUMAN; PRIMER DNA;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DRINKING BEHAVIOR; FAMILIAL CANCER; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN METHYLATION; SEX RATIO; SMOKING HABIT; TUMOR LOCALIZATION; TUMOR VOLUME; ADENOMA; AGING; CODON; COLORECTAL TUMOR; GENETICS; METABOLISM; METHYLATION; MIDDLE AGED; MUTATION; ONCOGENE RAS; PATHOLOGY; SMOKING;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; AGING; CODON; COLORECTAL NEOPLASMS; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, RAS; HUMANS; MALE; METHYLATION; MIDDLE AGED; MUTATION; SMOKING;

EID: 67649888951     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01140.x     Document Type: Article

References (49)

1. Baylin SB, Herman JG, Graff JR. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998, 72:141-96.
2. Esteller M, Risques RA, Toyota M. Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is associated with the presence of G : C to A : T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001, 61:4689-92.
3. Esteller M, Toyota M, Sanchez-Cespedes M. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000, 60:2368-71.
4. Shen L, Kondo Y, Rosner GL. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005, 97:1330-8.
5. Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002, 3:83-8.
6. Herman JG, Umar A, Polyak K. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998, 95:6870-5.
7. Hawkins N, Norrie M, Cheong K. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002, 122:1376-87.
8. Caldwell GM, Jones C, Gensberg K. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 2004, 64:883-8.
9. Caldwell GM, Jones CE, Taniere P. The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas. Br J Cancer 2006, 94:922-7.
10. Suzuki H, Watkins DN, Jair KW. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004, 36:417-22.
11. Harada K, Hiraoka S, Kato J. Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features. Br J Cancer 2007, 97:1425-31.
12. Akino K, Toyota M, Suzuki H. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 2005, 129:156-69.
13. Toyota M, Ahuja N, Ohe-Toyota M. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999, 96:8681-6.
14. Issa JP, Ottaviano YL, Celano P. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994, 7:536-40.
15. Toyota M, Issa JP. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 1999, 9:349-57.
16. Kawakami K, Ruszkiewicz A, Bennett G. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 2006, 94:593-8.
17. Nakagawa H, Nuovo GJ, Zervos EE. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001, 61:6991-5.
18. Issa JP. Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 1999, 32:31-43.
19. Ahuja N, Li Q, Mohan AL. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998, 58:5489-94.
20. Eads CA, Danenberg KD, Kawakami K. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32.
21. Woodson K, Weisenberger DJ, Campan M. Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 2005, 14:1219-23.
22. Hamilton SRAL. Pathology and genetics of tumours of the digestive system. WHO Classification of Tumours 2000, Vol. 2. Lyon, IARC
23. Hiraoka S, Kato J, Tatsukawa M. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology 2006, 131:379-89.
24. Eads CA, Lord RV, Wickramasinghe K. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001, 61:3410-18.
25. Widschwendter M, Siegmund KD, Muller HM. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 2004, 64:3807-13.
26. Virmani AK, Tsou JA, Siegmund KD. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Cancer Epidemiol Biomarkers Prev 2002, 11:291-7.
27. Hesson LB, Wilson R, Morton D. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene 2005, 24:3987-94.
28. Shannon B, Kay P, House A. Hypermethylation of the MYF-3 gene in colorectal cancers: associations with pathological features and with microsatellite instability. Int J Cancer 1999, 84:109-13.
29. Xu X, Thomas ML. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol 1994, 105:197-201.
30. Di Domenico M, Castoria G, Bilancio A. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 1996, 56:4516-21.
31. English MA, Stewart PM, Hewison M. Estrogen metabolism and malignancy: analysis of the expression and function of 17β-hydroxysteroid dehydrogenases in colonic cancer. Mol Cell Endocrinol 2001, 171:53-60.
32. Schwartz B, Smirnoff P, Shany S. Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol Cell Biochem 2000, 203:87-93.
33. Smirnoff P, Liel Y, Gnainsky J. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 1999, 11:255-64.
34. Kennelly R, Kavanagh DO, Hogan AM. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008, 9:385-91.
35. Fernandez E, La Vecchia C, Braga C. Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 1998, 7:329-33.
36. Calle EE, Miracle-McMahill HL, Thun MJ. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995, 87:517-23.
37. Calle EE. Hormone replacement therapy and colorectal cancer: interpreting the evidence. Cancer Causes Control 1997, 8:127-9.
38. Povey AC, Badawi AF, Cooper DP. DNA alkylation and repair in the large bowel: animal and human studies. J Nutr 2002, 132:3518S-21S.
39. Pegg AE. Repair of O6-alkylguanine by alkyltransferases. Mutat Res 2000, 462:83-100.
40. Kaina B, Ochs K, Grosch S. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis. Prog Nucleic Acid Res Mol Biol 2001, 68:41-54.
41. Gazin C, Wajapeyee N, Gobeil S. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007, 449:1073-7.
42. Weisenberger DJ, Siegmund KD, Campan M. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006, 38:787-93.
43. Shen L, Toyota M, Kondo Y. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 2007, 104:18654-9.
44. Shaw S, Jayatilleke E, Herbert V. Cleavage of folates during ethanol metabolism: Role of acetaldehyde/xanthine oxidase-generated superoxide. Biochem J 1989, 257:277-80.
45. Romero JJ, Tamura T, Halsted CH. Intestinal absorption of [3H]folic acid in the chronic alcoholic monkey. Gastroenterology 1981, 80:99-102.
46. Eichner ER, Hillman RS. The evolution of anemia in alcoholic patients. Am J Med 1971, 50:218-32.
47. Barak AJ, Beckenhauer HC, Tuma DJ. Hepatic transmethylation and blood alcohol levels. Alcohol 1991, 26:125-8.
48. Kenyon SH, Nicolaou A, Gibbons WA. The effect of ethanol and its metabolites upon methionine synthase activity in vitro. Alcohol 1998, 15:305-9.
49. Slattery ML, Curtin K, Anderson K. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res 2000, 60:6935-41.